Annual Total Liabilities
$441.00 K
-$148.00 K-25.13%
December 31, 2023
Summary
- As of February 10, 2025, MACK annual total liabilities is $441.00 thousand, with the most recent change of -$148.00 thousand (-25.13%) on December 31, 2023.
- During the last 3 years, MACK annual total liabilities has fallen by -$329.00 thousand (-42.73%).
Performance
MACK Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$22.67 M
+$22.23 M+5041.04%
March 1, 2024
Summary
- As of February 10, 2025, MACK quarterly total liabilities is $22.67 million, with the most recent change of +$22.23 million (+5041.04%) on March 1, 2024.
- Over the past year, MACK quarterly total liabilities has increased by +$22.18 million (+4498.78%).
Performance
MACK Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MACK Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.1% | +4498.8% |
| 3 y3 years | -42.7% | +4498.8% |
| 5 y5 years | -98.5% | +4498.8% |
MACK Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.1% | at low | at high | -98.2% |
| 5 y | 5-year | -84.1% | at low | at high | -98.2% |
| alltime | all time | -99.9% | at low | -94.6% | -98.2% |
Merrimack Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $22.67 M(+5041.0%) |
| Dec 2023 | $441.00 K(-25.1%) | $441.00 K(-10.5%) |
| Sep 2023 | - | $493.00 K(+20.0%) |
| Jun 2023 | - | $411.00 K(-11.2%) |
| Mar 2023 | - | $463.00 K(-21.4%) |
| Dec 2022 | $589.00 K(+4.8%) | $589.00 K(+31.5%) |
| Sep 2022 | - | $448.00 K(+1.6%) |
| Jun 2022 | - | $441.00 K(-21.8%) |
| Mar 2022 | - | $564.00 K(+0.4%) |
| Dec 2021 | $562.00 K(-27.0%) | $562.00 K(-17.7%) |
| Sep 2021 | - | $683.00 K(-11.5%) |
| Jun 2021 | - | $772.00 K(+12.9%) |
| Mar 2021 | - | $684.00 K(-11.2%) |
| Dec 2020 | $770.00 K(-72.2%) | $770.00 K(-65.3%) |
| Sep 2020 | - | $2.22 M(-5.0%) |
| Jun 2020 | - | $2.33 M(-29.2%) |
| Mar 2020 | - | $3.30 M(+19.0%) |
| Dec 2019 | $2.77 M(-90.7%) | $2.77 M(-41.5%) |
| Sep 2019 | - | $4.74 M(-5.1%) |
| Jun 2019 | - | $5.00 M(-80.3%) |
| Mar 2019 | - | $25.39 M(-14.6%) |
| Dec 2018 | $29.72 M(+41.3%) | $29.72 M(-19.4%) |
| Sep 2018 | - | $36.87 M(+105.4%) |
| Jun 2018 | - | $17.95 M(-1.6%) |
| Mar 2018 | - | $18.24 M(-13.3%) |
| Dec 2017 | $21.04 M | $21.04 M(-75.6%) |
| Sep 2017 | - | $86.21 M(-19.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $106.94 M(-68.9%) |
| Mar 2017 | - | $344.38 M(+3.1%) |
| Dec 2016 | $334.14 M(-20.2%) | $334.14 M(-3.2%) |
| Sep 2016 | - | $345.19 M(-1.8%) |
| Jun 2016 | - | $351.58 M(-14.3%) |
| Mar 2016 | - | $410.13 M(-2.0%) |
| Dec 2015 | $418.57 M(+60.6%) | $418.57 M(+71.7%) |
| Sep 2015 | - | $243.83 M(-1.8%) |
| Jun 2015 | - | $248.38 M(-3.1%) |
| Mar 2015 | - | $256.24 M(-1.7%) |
| Dec 2014 | $260.58 M(+10.6%) | $260.58 M(-9.6%) |
| Sep 2014 | - | $288.32 M(+39.3%) |
| Jun 2014 | - | $206.93 M(-10.4%) |
| Mar 2014 | - | $230.95 M(-2.0%) |
| Dec 2013 | $235.54 M(+51.6%) | $235.54 M(-2.1%) |
| Sep 2013 | - | $240.50 M(+45.4%) |
| Jun 2013 | - | $165.42 M(+3.8%) |
| Mar 2013 | - | $159.39 M(+2.6%) |
| Dec 2012 | $155.39 M(+45.2%) | $155.39 M(+41.0%) |
| Sep 2012 | - | $110.19 M(+4.3%) |
| Jun 2012 | - | $105.62 M(-71.9%) |
| Mar 2012 | - | $376.28 M(+251.7%) |
| Dec 2011 | $106.99 M(-61.3%) | $106.99 M(-70.5%) |
| Sep 2011 | - | $363.29 M(+0.5%) |
| Jun 2011 | - | $361.30 M(+21.9%) |
| Mar 2011 | - | $296.31 M(+7.2%) |
| Dec 2010 | $276.51 M(+1.3%) | $276.51 M |
| Dec 2009 | $272.92 M | - |
FAQ
- What is Merrimack Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual total liabilities year-on-year change?
- What is Merrimack Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly total liabilities year-on-year change?
What is Merrimack Pharmaceuticals annual total liabilities?
The current annual total liabilities of MACK is $441.00 K
What is the all time high annual total liabilities for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual total liabilities is $418.57 M
What is Merrimack Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, MACK annual total liabilities has changed by -$148.00 K (-25.13%)
What is Merrimack Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of MACK is $22.67 M
What is the all time high quarterly total liabilities for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly total liabilities is $418.57 M
What is Merrimack Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, MACK quarterly total liabilities has changed by +$22.18 M (+4498.78%)